Intersect ENT wins FDA nod for Sinuva polyp-disease-treating sinus implant
Intersect ENT (NSDQ:XENT) said today it won FDA approval for its Sinuva mometasone furoate sinus implant designed to treat recurrent nasal polyp disease in patients who have previously had ethmoid sinus surgery.
The Sinuva device is designed to be implanted during a routine physician office visit and expands into the sinus cavity to deliver an anti-inflammatory steroid directly to the site of the polyp disease for 90 days.
Read the whole story on our sister site, Drug Delivery Business
The post Intersect ENT wins FDA nod for Sinuva polyp-disease-treating sinus implant appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - December 11, 2017 Category: Medical Devices Authors: Fink Densford Tags: Drug-Device Combinations Food & Drug Administration (FDA) Otolaryngology Ear, Nose & Throat Regulatory/Compliance intersectent Source Type: news
Elocon (Mometasone Furoate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 27, 2017 Category: Drugs & Pharmacology Source Type: news
Elocon Lotion (Mometasone Furoate Lotion) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 27, 2017 Category: Drugs & Pharmacology Source Type: news
Elocon Ointment (Mometasone Furoate Ointment) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 27, 2017 Category: Drugs & Pharmacology Source Type: news
Amneal Introduces Its First Nasal Spray: Generic Nasonex(R)
BRIDGEWATER, N.J., April 11, 2017 -- (Healthcare Sales & Marketing Network) -- Amneal Pharmaceuticals LLC has launched mometasone furoate nasal spray, the company's first pharmaceutical product in spray form. Mometasone furoate, available in 50 mcg/spray... Biopharmaceuticals, Generics, Drug Delivery, Product Launch Amneal Pharmaceuticals, mometasone furoate, nasal spray, Nasonex (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 11, 2017 Category: Pharmaceuticals Source Type: news
Nasonex (Mometasone Furoate (nasal spray)) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 13, 2016 Category: Drugs & Pharmacology Source Type: news
Intersect ENT claims reimbursement win for Propel drug-eluting sinus implant
Intersect ENT (NSDQ:XENT) said today that it won a positive coverage decision from CareFirst BlueCross BlueShield for its Propel and Propel Mini drug-eluting sinus implants.
The devices are designed to elute the anti-inflammatory steroid mometasone furoate; Menlo Park, Calif.-based Intersect won FDA approval for the original Propel implant in August 2011 and for the Propel Mini the following September. The implants are designed to dissolve into the body over time.
CareFirst BlueCross BlueShield has some 3.2 million lives under coverage in Washington, D.C., Maryland and northern Virginia, including more than 577,000 in...
Source: Mass Device - August 29, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Drug-Device Combinations Ear Nose & Throat (ENT) Intersect ENT Inc. Reimbursement Source Type: news
Morphologi G3-ID Used by FDA to Approve a New Nasal Spray
Key data for the approval of a nasal spray containing mometasone furoate has been obtained by the Food and Drug Administration (FDA) through the use of Malvern's Morphologi G3-ID system. (Source: Drug Development Technology)
Source: Drug Development Technology - August 18, 2016 Category: Pharmaceuticals Source Type: news
FDA Uses Malvern's Bioequivalence Evaluation Technology
The food and drug administration (FDA) has used Malvern's Morphologi G3-ID system to generate key data for the approval of the first generic nasal spray containing mometasone furoate. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 18, 2016 Category: Pharmaceuticals Source Type: news
Dulera (Mometasone Furoate, Formoterol Fumarate Dihydrate Inhalation) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 25, 2016 Category: Drugs & Pharmacology Source Type: news
Generic Nasonex Nasal Spray Approved (FREE)
By Kristin J. Kelley
Edited by David G. Fairchild, MD, MPH
The first generic version of mometasone furoate monohydrate (Nasonex nasal spray) has … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 22, 2016 Category: Primary Care Source Type: news
Apotex Launches First Generic Version of Merck's Nasonex(R)
TORONTO, March 22, 2016 -- (Healthcare Sales & Marketing Network) - Apotex Inc. announced today that it has launched the first generic version of Merck's Nasonex® nasal spray (mometasone furoate monohydrate) in the United States.
Apotex's mometas... Biopharmaceuticals, Generics, Product LaunchApotex, Nasonex, mometasone furoate, Merck (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 22, 2016 Category: Pharmaceuticals Source Type: news
Intersect ENT logs German reimbursement win
Intersect ENT (NSDQ:XENT) said today it clocked a German hospital reimbursement win from InEk, Germany’s Institute for Hospital Remuneration System, for its Propel sinus implant.
The propel device is a small steroid releasing implant designed to improve surgical outcomes for patients with chronic sinusitis undergoing ethmoid sinus surgery.
“We believe that the robust clinical evidence supporting Propel was key to this favorable decision, which we received on the 1st application round. While our focus as a company is very much on U.S. commercialization as well as development of our pipeline products, this repres...
Source: Mass Device - January 29, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Drug-Device Combinations Otolaryngology Ear, Nose & Throat Regulatory/Clearance Intersect ENT Inc. Source Type: news
Application of Mometasone Furoate in Vulvar Lichen SclerosusApplication of Mometasone Furoate in Vulvar Lichen Sclerosus
What's the optimal regimen of topical corticosteroids for treatment of vulvar lichen sclerosus? The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 27, 2016 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Dulera (mometasone furoate/formoterol fumarate)
Title: Dulera (mometasone furoate/formoterol fumarate)Category: MedicationsCreated: 10/21/2015 12:00:00 AMLast Editorial Review: 10/21/2015 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - October 21, 2015 Category: Respiratory Medicine Source Type: news
